StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

Analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued on Wednesday. The firm set a “hold” rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Price Performance

NYSE MLSS opened at $1.28 on Wednesday. The business has a fifty day moving average price of $0.99 and a two-hundred day moving average price of $0.93. The stock has a market capitalization of $99.70 million, a PE ratio of -18.28 and a beta of 1.10. Milestone Scientific has a fifty-two week low of $0.54 and a fifty-two week high of $1.39.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of MLSS. Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific during the third quarter worth about $48,000. World Investment Advisors LLC bought a new position in Milestone Scientific during the 3rd quarter worth approximately $91,000. Carnegie Investment Counsel lifted its position in shares of Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares during the period. Finally, Geode Capital Management LLC boosted its stake in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the last quarter. 5.79% of the stock is owned by institutional investors and hedge funds.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.